Clinical Trial Update: Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART [NA]

View source ↗

Summary

A completed clinical trial assessed whether L-Carnitine improves postprandial clearance of triglyceride-rich lipoproteins in HIV patients on HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: University of California, Davis | Conditions: Hyperlipidemia, HIV Infections | NA | Status: COMPLETED